UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000010160
Receipt No. R000011896
Scientific Title Phase II trial as new chemotherapy regimen for bevacizumab (Bev) in combination with XELOX in unresectable colorectal cancer.
Date of disclosure of the study information 2013/04/01
Last modified on 2019/01/18 17:08:29

No. Disposal Last modified on Item of update
1 Insert 2013/03/04 22:02:36
2 Update 2014/09/04 20:42:37 TEL
Email
Last name of contact person
Last name of contact person
Address
TEL
Email
3 Update 2014/09/04 20:43:55 Recruitment status
4 Update 2015/09/04 19:15:28 Recruitment status
5 Update 2019/01/18 17:08:29 Recruitment status
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Results


Contact us.